FDA WARNING_LETTER - Vivot LLC - May 04, 2026
Discuss this record with AI
On June 8, 2026, the FDA issued a warning letter to Vivot LLC, a company based in Fullerton, California, following an inspection on May 4, 2026. The inspection aimed to determine if the company was compliant with the Foreign Supplier Verification Program (FSVP) requirements established under the Federal Food, Drug, and Cosmetic Act. These regulations require importers to perform risk-based activities to ensure that food products imported into the United States meet domestic safety standards. The primary violation identified was that Vivot LLC failed to develop, maintain, or follow an FSVP for any of the products it imports. Specifically, the FDA noted the absence of safety verification programs for Green Tea Powder Matcha, Matcha Powder, and other Green Tea products sourced from foreign suppliers. Consequently, the company failed to prove that its foreign suppliers produce food in a manner that provides the same level of public health protection as U.S. law. Vivot LLC is required to respond in writing within 15 working days, providing documentation that demonstrates corrective actions, such as copies of newly established verification programs. Failure to address these violations may lead to the FDA refusing admission of the company"s imports or placing their products on a detention list, which allows the agency to hold shipments without physical examination.
ID · d31b87ee-6d96-4cd7-93cf-9c6ee63ad124
Full citation text and observation details available on the Dashboard.